Retatrutide Prescribed Online to Florida Residents
Medical Weight Loss Treatment in Florida
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Key Benefits
- Triple receptor mechanism: GLP-1 + GIP + glucagon for amplified metabolic effect
- Phase 2 data shows 24.2% average weight loss at 48 weeks (12mg dose)
- ~58% hepatic fat reduction in Phase 2 sub-group analyses
- Elevated basal metabolic rate via glucagon receptor agonism
- Research-grade purity ≥98% with full CoA, HPLC, and MS documentation
Who is a Good Candidate?
Intended for laboratory researchers and pre-clinical study investigators studying triple receptor agonism, obesity mechanisms, hepatic metabolism, or GLP/GIP/glucagon signaling pathways. Listed for research-use only (RUO) — not for human therapeutic use.
Available for research use
Serving Florida
The Sunshine State's diverse population deserves healthcare as dynamic as Florida itself. From the retirees of The Villages to the young professionals of Miami, the families of Tampa Bay to the snowbirds of Naples, OmniRx Health serves all Floridians. Our telehealth platform eliminates traffic jams on I-95, waits at crowded clinics, and the challenge of finding specialists in rural areas—bringing expert care directly to your lanai, condo, or beach house.
OmniRx Health providers hold active Florida Board of Medicine licenses, ensuring compliant telehealth delivery across all 67 counties.
Florida's extensive pharmacy network—from Miami to Jacksonville to the Panhandle—ensures rapid prescription fulfillment with convenient home delivery options.
Florida's telehealth laws are comprehensive, allowing licensees to practice across the state via secure video platforms with full prescriptive authority.
Florida requires telehealth coverage parity for most insurance plans, and Medicare's expanded telehealth benefits serve the state's significant 65+ population.
Frequently Asked Questions
- What is retatrutide and how does it work?
- Retatrutide (CAS 2381089-83-2) is a 39-amino acid synthetic peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This triple agonism produces coordinated appetite suppression (GLP-1), amplified insulin and fat-cell metabolism (GIP), and increased hepatic glucose output and resting energy expenditure (glucagon). It is currently in Phase 3 clinical trials and is available for research-use only (RUO).
- How does retatrutide compare to semaglutide and tirzepatide in research?
- Phase 2 data (NEJM, 2023) showed retatrutide at 12mg produced 24.2% average weight loss at 48 weeks, outperforming semaglutide (~15% at 68 weeks) and tirzepatide (~22% at 72 weeks) in their respective trials. Retatrutide adds glucagon receptor agonism — absent in both comparators — which appears to drive additional metabolic rate elevation and hepatic fat clearance.
- Is retatrutide available for human use?
- No. Retatrutide has not received FDA approval for any human therapeutic use. It is currently in Phase 3 (TRIUMPH) clinical trials and is listed by OmniRx strictly as a research-use only (RUO) compound for laboratory and pre-clinical research applications.
- Is telehealth legal in Florida?
- Yes, telehealth is fully legal and thriving in Florida. The state has embraced virtual healthcare, with laws supporting provider licensing, patient privacy, and prescription delivery across all 67 counties.
- Can Florida Medicare patients use telehealth?
- Absolutely. Medicare has expanded telehealth coverage significantly, and Florida's large Medicare population can access virtual consultations, follow-ups, and prescription services through platforms like OmniRx Health.
- Is telehealth good for Florida's rural areas?
- Telehealth is transforming healthcare access in rural Florida. Residents in agricultural communities, the Panhandle, and remote coastal areas can now access specialists without driving hours to urban medical centers.